COMP <GO>
MCK vs JNJ // 10Y YIELD & FRED MACRO BETA
McKesson Corporation (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: MCK 8
— JNJ 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: JNJ
LAST: $994.58 (+1.40%) • MKT CAP: $114.36B
macro-sensitivity
0.95
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MCK VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MCK | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 67.90% | -64.30 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 38.60% | 25.50% | +13.10 | MCK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 18.5x | +1.00 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 5.00% | 2.97% | +2.03 | MCK | /fcf-yield <GO> |
| Operating Margin | 1.50% | 34.70% | -33.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 28.50% | -27.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 12.40% | 6.00% | +6.40 | MCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.33% | 0.00% | +0.33 | MCK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.96 | 5.59 | +1.37 | MCK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.20% | -0.50 | MCK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.7 | 60.4 | +0.31 | MCK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.95 | 1.08 | -0.13 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 23.0x | -2.80 | MCK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $114.36B | $662.49B | -$548.13B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MCK REV | JNJ REV | MCK GROSS % | JNJ GROSS % | MCK FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $403.43B | $94.19B | 3.6% | 67.9% | $5.72B | $19.70B |
| FY 2024 | $359.05B | $88.82B | 3.7% | 69.1% | $5.55B | $19.84B |
| FY 2023 | $308.95B | $85.16B | 44.0% | 44.0% | -$9.59B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MCK // BETA 0.95
JNJ // BETA 1.08